Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements
Ae-Ryeo Cho, Byeong-Chan Oh, Jin Hyun Nam, Min Ji Kim, So-Young Yang, Sun-Hong Kwon, 이의경
BMC CANCER, 202305
23
Comparative Safety Profiles of Oncology Biosimilars: A Systematic Review and Network Meta-analysis
Economic Burden of Recurrence in Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer: A Retrospective Study Using Nationwide Claims Data of South Korea
이의경
ADVANCES IN THERAPY, 202302
25
Real-World Effectiveness of Palbociclib With Concomitant Proton Pump Inhibitor in Patients With Breast Cancer in South Korea: A Retrospective Cohort Study
이의경
VALUE IN HEALTH, 202212
26
Real-World Effectiveness of CDK 4/6 Inhibitor as First-Line Treatment in Patients With HR+, HER2-Advanced Breast Cancer in South Korea - Focused on Underrepresented Younger and Older Age
이의경
VALUE IN HEALTH, 202212
27
HEALTHCARE RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS WITHOUT EGFR MUTATIONS OR ALK REARRANGEMENTS IN KOREA
이의경
VALUE IN HEALTH, 202212
28
COST-EFFECTIVENESS OF EVEROLIMUS COMBINATION THERAPY IN PATIENTS AFTER LIVER TRANSPLANTATION FOCUSING ON CANCER RISK: A MARKOV MODEL USING REAL-WORLD DATA
이의경
VALUE IN HEALTH, 202212
29
COMPARISON OF CLINICAL OUTCOMES IN DE NOVO VERSUS RELAPSED/PROGRESSED ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS WITHOUT EGFR MUTATIONS OR ALK REARRANGEMENTS
이의경
VALUE IN HEALTH, 202212
30
COST-EFFECTIVENESS OF ADHERENCE INTERVENTION FOR TUBERCULOSIS TREATMENTS IN SOUTH KOREA USING DISCRETE EVENT SIMULATION MODEL